Drug
Ptc923
Ptc923: highest development phase Phase 3, developed by PTC Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PTC923 NCT05099640 | Phase 3 | Phenylketonuria |
| PTC923 NCT05166161 | Phase 3 | Phenylketonuria |
Latest
No recent events.
Follow Ptc923 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.